Daiichi Sankyo Company, Limited DSKYF
17.71 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
19.25 Day range 19.25
13.85 52-week range 25.75
- YTD
- -17.63%
- 1 year
- -18.35%
- Market cap
- 32.27B
- EPS (ttm)
- 0.97
- P/E ratio
- 18.26
- YTD return
- -17.63%
- 1-year return
- -18.35%
- Volume
- 500
- Avg volume
- 4.11K
- Open
- 19.25
- Previous close
- 17.71
- Day's range
- 19.25 – 19.25
- 52-week range
- 13.85 – 25.75
- Earnings date
- Nov 4, 2026
No chart data for this range yet.
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.241.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.241 | — | — | — |
| Jul 31, 2026 | Jun 30, 2026 | 0.2521 | 0.2319 | -0.02 | -8.01% |
| May 11, 2026 | Mar 31, 2026 | 0.3304 | 0.1455 | -0.18 | -55.96% |
| Jan 29, 2026 | Dec 31, 2025 | 0.2498 | 0.2986 | +0.05 | +19.54% |
| Oct 31, 2025 | Sep 30, 2025 | 0.303 | 0.1658 | -0.14 | -45.28% |
| Jul 31, 2025 | Jun 30, 2025 | 0.2374 | 0.3194 | +0.08 | +34.54% |
News
Daiichi Sankyo Reports Second Quarter Fiscal Year 2026 Financial Results 
Two Single-Pill Triple Combination Lipid-Lowering Therapy Applications Validated in The European Union 
Daiichi Sankyo Gets $75M Milestone From AstraZeneca After EU Approves Enhertu For Adjuvant HER2 Positive Early Breast Cancer; DESTINY-Breast05 Showed 53% Lower Recurrence Or Death Risk Versus T-DM1 
Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO 
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination 
Merck, Daiichi Sankyo withdraw US application for lung cancer drug 
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization 
Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results 
Daiichi Sankyo Company, Limited (DSNKY) Q4 2026 Earnings Call Transcript 
Daiichi Sankyo Company, Limited (DSKYF) Q1 FY2025 Earnings Call Transcript
Your note
Sign in to keep a note on DSKYF — it syncs with the Stock Master app.